The announcement of a class action lawsuit against Kyverna Therapeutics, Inc. is likely to negatively impact its stock price in the short term as investors may react to the potential legal and financial consequences. Legal issues can lead to uncertainty and potential financial liabilities, which typically result in a negative market reaction.